Location: New York, NY
CIK: 0001263508 · Show all filings
Period: Q2 2014 (← Previous) (Next →)
Filing Date: Aug 14, 2014
Total Value: $8.164B (75.6% shares, 24.4% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Synageva Biopharma Corp. | 10,660,432 | $1.117B | 13.7% | $45.53 | — | COM | 87159A103 |
| — | Pharmacyclics Inc. | 9,591,546 | $860M | 10.5% | $80.38 | — | COM | 716933106 |
| — | Seattle Genetics, Inc. | 22,472,229 | $860M | 10.5% | $32.51 | — | COM | 812578102 |
| INCY | Incyte Corp. | 14,845,559 | $838M | 10.3% | $21.85 | +133.8% | COM | 45337C102 |
| — | Salix 2.75% 5/15/15 | 219,440,000 | $586M | 7.2% | $1.52 | — | CONV BONDS | 795435AC0 |
| ACAD | Acadia Pharmaceuticals Inc. | 20,481,442 | $463M | 5.7% | $14.07 | +48.4% | COM | 004225108 |
| — | Genomic Health Inc. | 13,654,902 | $374M | 4.6% | $31.71 | — | COM | 37244C101 |
| — | Incyte Corporation Notes 1.25% 11/15/2020 144A | 274,500,000 | $372M | 4.6% | $1.21 | — | CONV BONDS | 45337CAL6 |
| — | Incyte Corporation Notes 0.375% 11/15/2018 144A | 259,000,000 | $346M | 4.2% | $1.20 | — | CONV BONDS | 45337CAK8 |
| — | Incyte Corporation Notes 4.75% 10/1/2015 144A | 40,446,000 | $259M | 3.2% | $6.08 | — | CONV BONDS | 45337CAJ1 |
| — | Intermune Inc. | 4,722,869 | $209M | 2.6% | $33.77 | — | COM | 45884X103 |
| — | Intermune Inc Notes 2.5% 12/15/17 | 41,000,000 | $141M | 1.7% | $1.07 | — | CONV BONDS | 45884XAF0 |
| BCRX | Biocryst Pharmaceuticals Inc. | 10,890,872 | $139M | 1.7% | $5.72 | +70.0% | COM | 09058V103 |
| BMRN | Biomarin Pharmaceuticals | 1,908,230 | $119M | 1.5% | $65.58 | -7.9% | COM | 09061G101 |
| — | Xoma Corp. | 23,065,972 | $106M | 1.3% | $3.73 | — | COM | 98419J107 |
| — | Avanir Pharmaceuticals | 18,558,487 | $105M | 1.3% | $5.21 | — | COM CLASS A | 05348P401 |
| — | Gilead 1.625% 5/1/16 | 21,500,000 | $78.36M | 1.0% | $2.26 | — | CONV BONDS | 375558AP8 |
| VNDA | Vanda Pharmaceuticals, Inc. | 4,372,153 | $70.74M | 0.9% | $7.41 | +79.6% | COM | 921659108 |
| — | Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 | 22,898,000 | $70.51M | 0.9% | $2.76 | — | CONV BONDS | 09061GAD3 |
| — | Anacor Pharmaceuticals | 3,248,043 | $57.59M | 0.7% | $17.42 | — | COM | 032420101 |
| — | Medivation 2.625% 4/1/17 | 34,720,000 | $55.32M | 0.7% | $1.27 | — | CONV BONDS | 58501NAA9 |
| — | Dyax Corp. | 5,681,237 | $54.54M | 0.7% | $8.81 | — | COM | 26746E103 |
| — | Repros Therapeutics | 2,778,654 | $48.07M | 0.6% | $18.45 | — | COM | 76028H209 |
| — | Mirati Therapeutics Inc. | 2,380,074 | $47.6M | 0.6% | $15.40 | — | COM | 60468T105 |
| — | Questcor Pharmaceuticals, Inc. | 500,000 | $46.24M | 0.6% | $51.83 | — | COM | 74835Y101 |
| CERS | Cerus | 10,246,591 | $42.52M | 0.5% | $4.74 | -9.7% | COM | 157085101 |
| — | Derma Sciences | 3,537,137 | $40.89M | 0.5% | $12.84 | — | COM | 249827502 |
| — | Intermune Inc Notes 5% 3/1/15 | 16,860,000 | $39.84M | 0.5% | $1.05 | — | CONV BONDS | 45884XAD5 |
| — | Versartis Inc. | 1,245,889 | $34.94M | 0.4% | $28.04 | — | COM | 92529L102 |
| — | Clovis Oncology | 793,221 | $32.85M | 0.4% | $56.56 | — | COM | 189464100 |
| HRTX | Heron Therapeutics, Inc. | 2,607,784 | $32.13M | 0.4% | $12.49 | -4.4% | COM | 427746102 |
| — | Acorda Therapeutics, Inc. | 906,091 | $30.54M | 0.4% | $37.91 | — | COM | 00484M106 |
| — | Salix 1.5% 3/15/19 | 15,000,000 | $29.45M | 0.4% | $1.49 | — | CONV BONDS | 795435AE6 |
| HALO | Halozyme Therapeutics Inc. | 2,776,143 | $27.43M | 0.3% | $6.50 | +30.5% | COM | 40637H109 |
| GILD | Gilead Sciences Inc. | 256,108 | $21.23M | 0.3% | $36.21 | +49.3% | COM | 375558103 |
| — | Arrowhead Research Corp. | 1,430,802 | $20.48M | 0.3% | $9.90 | — | COM | 042797209 |
| TGTX | TG Therapeutics | 2,160,965 | $20.29M | 0.2% | $4.61 | +38.8% | COM | 88322Q108 |
| — | Xenoport | 4,034,112 | $19.48M | 0.2% | $5.11 | — | COM | 98411C100 |
| — | Progenics Pharmaceuticals, Inc. | 4,449,797 | $19.18M | 0.2% | $4.44 | — | COM | 743187106 |
| — | Salix Pharmaceuticals Ltd Put 110 July 14 | 125,100 | $15.43M | 0.2% | $123.35 | — | COM | 795435956 |
| — | Aegerion Pharmaceuticals | 413,922 | $13.28M | 0.2% | $62.87 | — | COM | 00767E102 |
| OMER | Omeros Corp. | 753,804 | $13.12M | 0.2% | $7.18 | +75.6% | COM | 682143102 |
| — | Biomarin Pharmaceuticals Notes 0.75% 10/15/2018 | 12,500,000 | $12.89M | 0.2% | $1.06 | — | CONV BONDS | 09061GAE1 |
| — | Kythera Biopharmaceuticals | 311,255 | $11.94M | 0.1% | $34.55 | — | COM | 501570105 |
| — | Aquinox Pharmaceuticals, Inc. | 1,211,851 | $11.36M | 0.1% | $12.73 | — | COM | 03842B101 |
| — | QLT Inc. | 1,535,863 | $9.492M | 0.1% | $4.39 | — | COM | 746927102 |
| AGIO | Agios Pharmaceuticals | 199,893 | $9.159M | 0.1% | $27.47 | +48.4% | COM | 00847X104 |
| NBIX | Neurocrine Biosciences, Inc. | 554,590 | $8.23M | 0.1% | $16.53 | -14.6% | COM | 64125C109 |
| SGMO | Sangamo Biosceiences, Inc. | 522,764 | $7.983M | 0.1% | $12.44 | +15.6% | COM | 800677106 |
| — | Osiris Therapeutics Inc. | 510,606 | $7.976M | 0.1% | $16.34 | — | COM | 68827R108 |
| INFIQ | Infinity Pharmaceuticals Inc. | 624,050 | $7.95M | 0.1% | $13.42 | -22.4% | COM | 45665G303 |
| — | Bluebird Bio Inc. | 198,260 | $7.647M | 0.1% | $25.09 | — | COM | 09609G100 |
| — | Aerie Pharmaceuticals | 299,356 | $7.415M | 0.1% | $17.96 | — | COM | 00771V108 |
| — | Threshold Pharma | 1,826,358 | $7.232M | 0.1% | $4.65 | — | COM | 885807206 |
| — | Synergy Pharmaceuticals | 1,758,271 | $7.156M | 0.1% | $4.32 | — | COM | 871639308 |
| IRWD | Ironwood Pharmaceuticals | 446,160 | $6.84M | 0.1% | $11.63 | -6.5% | COM | 46333X108 |
| MGNX | Macrogenics, Inc. | 311,891 | $6.777M | 0.1% | $22.61 | -7.0% | COM | 556099109 |
| — | Epizyme Inc. | 214,012 | $6.66M | 0.1% | $21.47 | — | COM | 29428V104 |
| — | Array Biopharma Inc. | 1,433,797 | $6.538M | 0.1% | $4.54 | — | COM | 04269X105 |
| — | Discovery Laboratories Inc. | 3,652,117 | $6.501M | 0.1% | $1.95 | — | COM | 254668403 |
| — | Tekmire Pharmaceuticals Corp. | 484,156 | $6.323M | 0.1% | $7.97 | — | COM | 87911B209 |
| XNCR | Xencor | 542,363 | $6.302M | 0.1% | $8.58 | +14.5% | COM | 98401F105 |
| INSM | Insmed Inc. | 304,050 | $6.075M | 0.1% | $10.61 | +39.5% | COM | 457669307 |
| — | Novavax Inc. | 1,223,362 | $5.652M | 0.1% | $3.15 | — | COM | 670002104 |
| — | Cytrx Corp. | 1,350,000 | $5.643M | 0.1% | $3.49 | — | COM | 232828509 |
| CPRX | Catalyst Pharmaceuticals, Inc. | 2,223,053 | $5.624M | 0.1% | $2.12 | +0.5% | COM | 14888U101 |
| — | Ignyta | 571,000 | $5.19M | 0.1% | $8.30 | — | COM | 451731103 |
| — | Ambit Biosciences Corp. | 747,954 | $5.168M | 0.1% | $7.00 | — | COM | 02318X100 |
| — | BioDelivery Sciences Intl. Inc. | 421,005 | $5.082M | 0.1% | $4.06 | — | COM | 09060J106 |
| — | Stemline Therapeutics Inc. | 338,671 | $4.968M | 0.1% | $23.84 | — | COM | 85858C107 |
| — | Zogenix, Inc. | 2,350,400 | $4.724M | 0.1% | $2.18 | — | COM | 98978L105 |
| — | Idera Pharmaceuticals Inc. | 1,613,076 | $4.678M | 0.1% | $0.91 | — | COM | 45168K306 |
| LGND | Ligand Pharmaceuticals | 73,400 | $4.572M | 0.1% | $41.68 | -2.7% | COM | 53220K504 |
| RARE | Ultragenyx Pharmaceuticals | 100,000 | $4.489M | 0.1% | $51.48 | -20.0% | COM | 90400D108 |
| — | Karyopharm Therapeutics | 94,095 | $4.38M | 0.1% | $31.71 | — | COM | 48576U106 |
| GALT | Galectin Therapeutics Inc. | 300,000 | $4.143M | 0.1% | $13.23 | -5.9% | COM | 363225202 |
| — | Concert Pharmaceuticals, Inc. | 398,800 | $4.028M | 0.0% | $10.10 | — | COM | 206022105 |
| — | Celsus Therapeutics | 673,887 | $3.706M | 0.0% | $6.49 | — | SPONSORED ADR NE | 15119A202 |
| — | Achillion | 438,337 | $3.318M | 0.0% | $8.18 | — | COM | 00448Q201 |
| — | Isis Pharmaceuticals, Inc. | 96,303 | $3.318M | 0.0% | $26.87 | — | COM | 464330109 |
| ENTA | Enanta Pharmaceuticals | 75,357 | $3.246M | 0.0% | $19.50 | +95.6% | COM | 29251M106 |
| — | Biota Pharmaceuticals | 1,106,910 | $3.155M | 0.0% | $4.19 | — | COM | 090694100 |
| — | Alder Biopharmaceuticals, Inc. | 153,350 | $3.078M | 0.0% | $20.07 | — | COM | 014339105 |
| — | Lipocine Inc. | 500,000 | $3.05M | 0.0% | $6.10 | — | COM | 53630X104 |
| — | Regado | 400,000 | $2.716M | 0.0% | $12.52 | — | COM | 75874Q107 |
| — | Mediwound Ltd. | 225,000 | $2.561M | 0.0% | $11.38 | — | COM | M68830104 |
| — | Foundation Medicine Inc. | 78,162 | $2.107M | 0.0% | $26.96 | — | COM | 350465100 |
| — | Synta Pharmaceuticals | 500,000 | $2.045M | 0.0% | $4.99 | — | COM | 87162T206 |
| — | La Jolla Pharmaceuticals, Inc. | 221,631 | $2.035M | 0.0% | $10.80 | — | COM | 503459604 |
| OSUR | Orasure Technologies Inc. | 234,664 | $2.02M | 0.0% | $4.46 | +57.2% | SHS | 68554V108 |
| — | Mast Therapeutics, Inc. | 3,000,000 | $1.887M | 0.0% | $0.63 | — | COM | 057631410 |
| — | Rigel Pharmaceuticals | 481,972 | $1.75M | 0.0% | $3.58 | — | COM | 766559603 |
| FOLD | Amicus Therapeutics | 481,697 | $1.609M | 0.0% | $3.07 | -23.6% | COM | 03152W109 |
| — | Ophthotech Corp. | 36,776 | $1.556M | 0.0% | $32.35 | — | COM | 683745103 |
| — | Achaogen Inc. | 100,000 | $1.396M | 0.0% | $15.46 | — | COM | 004449104 |
| GERN | Geron Corp. | 402,629 | $1.292M | 0.0% | $1.08 | +92.5% | COM | 374163103 |
| — | Salix Pharmaceuticals | 8,621 | $1.063M | 0.0% | $99.30 | — | COM | 795435106 |
| — | Receptos Inc. | 23,900 | $1.018M | 0.0% | $19.89 | — | COM | 756207106 |
| — | Ziopharm Oncology Inc. | 244,619 | $986K | 0.0% | $2.11 | — | COM | 98973P101 |
| — | Acceleron Pharma Inc. | 28,765 | $977K | 0.0% | $39.60 | — | COM | 00434H108 |
| — | Tesaro Inc. | 31,218 | $971K | 0.0% | $32.74 | — | COM | 881569107 |
| ALNY | Alnylam Pharmaceuticals, Inc. | 11,600 | $733K | 0.0% | $77.42 | -23.2% | COM | 02043Q107 |
| QURE | Uniquere B.V. | 30,672 | $417K | 0.0% | $15.95 | -31.8% | COM | N90064101 |
| — | Five Prime Therapeutics Inc. | 19,823 | $308K | 0.0% | $16.80 | — | COM | 33830X104 |
| — | Chemocentryx Inc. | 50,000 | $293K | 0.0% | $14.14 | — | COM | 16383L106 |
| — | Cyclacel Pharmaceuticals Pfd. Conv. Ex 6% | 13,253 | $108K | 0.0% | $7.20 | — | PFD CONV EX 6% | 23254L207 |